QPS will exhibit at the World Vaccine Congress, April 15-17 in Washington, DC. Please stop by our booth #600 to learn more about QPS’ capabilities in vaccine trials. Find out more at Vaccines or email: [email protected]
BREXIT IMPACT: More Questions Than Answers
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed in June 2016. Yet Britain’s exit, or “Brexit,” leaves us with more questions than answers right now. We have been watching and waiting, with clarity expected on March 29, 2019, the …
QPS is exhibiting at the 13th Annual WRIB Meeting
QPS is exhibiting at the 13th Annual WRIB Meeting, April 1-4 in New Orleans, LA. If you are attending, please visit us at booth #49. Contact us at [email protected] for additional information.
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28 to learn more about QPS’ contract research services. Find out more at qpsneuro.com or email [email protected]
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the meeting, please visit us to learn more about QPS’ range of services. We have supported gene therapy since 2002: ASOs, siRNAs, miRNA through mRNAs and viral vectors utilizing LC-HRMS, hybridization-LC, and …
Spreading Early Clinical Knowledge
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific literature. Learn more by reading: A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single …